Contineum Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Contineum Therapeutics, Inc. quarterly Earnings Per Share, Basic history and growth rate from Q1 2023 to Q3 2024.
  • Contineum Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.4 USD/shares, a 85.1% increase year-over-year.
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $0 +$2.29 +85.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $0 -$3 -115% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$4 -$1 -67.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-16
Q3 2023 -$3 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $2.56 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$2 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.